IWH Journal Articles

Export 6 results:
Sort by: Author Title [ Year (Desc)]
Filters: Author is Boers,M.  [Clear All Filters]
2009
Simon LS, Strand CV, Boers M, Brooks PM, Tugwell PS, Bombardier C, et al. How to ascertain drug safety in the context of benefit. Controversies and concerns. Journal of Rheumatology. 2009;36(9):2114-21. Abstract
2006
Beaton DE, Tugwell P, Boers M. Health outcomes assessment. In: Green's rheumatology.; 2006.
2005
Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, et al. Minimal disease activity for rheumatoid arthritis: a preliminary definition. Journal of Rheumatology. 2005;32(10):2016-24. Abstract
2002
Beaton DE, Boers M, Wells GA. Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Current Opinion in Rheumatology. 2002;14(2):109-14. Abstract
2001
Beaton DE, Bombardier C, Katz JN, Wright JG, Wells G, Boers M, et al. Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. Journal of Rheumatology. 2001;28(2):400-5. Abstract
Wells G, Beaton D, Shea B, Boers M, Simon L, Strand V, et al. Minimal clinically important differences: review of methods. Journal of Rheumatology. 2001;28(2):406-12. Abstract